# Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

> **NCT05524246** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 25 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplant (HSCT)
- Endothelial Injury

## Interventions

- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT05524246
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-27
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05524246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05524246, "Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05524246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*